Glivec.com is a [[parking lot]]
Title
Glivec International - Glivec, GIST, and CML Info for HCPs
Description
Traditional approaches to cancer treatment, such as chemotherapy and radiation, have been proven to eliminate cancerous cells, but at great cost: They often result in serious unwanted effects on healthy cells.
A signal transduction inhibitor, Glivec interferes with the pathways that signal the growth of some tumour cells, targeting the activity of tyrosine kinases enzymes, which play an important role in certain cancer cells.
In clinical studies, more than 90% of patients in chronic phase CML had their white blood cell counts return to normal and more than 79% had a major cytogenic response with Glivec. Recent studies have suggested that raising initial daily dosage to 800 mg increases effectiveness even further.
